Company /

Academic
Group

Product

Medtronic

- MiniMed 670G pump with

built in hybrid closed loop FDA submission
before end of June
algorithm (requires meal
2016; US launch
boluses)
hoped by April 2017
- Enlite 3 CGM

Tandem

Latest Timing

- Tandem t:slim pump with - Pivotal trial in 2016,

potential launch in
built in predictive low
glucose suspend algorithm; 2017
Dexcom CGM
- Tandem t:slim pump with
built in HypoglycemiaHyperglycemia Minimizer
algorithm; Dexcom CGM

- Pivotal study in
2017, potential
launch by end of
2018

International
- Commercial version of
International Diabetes
Diabetes
DiAs hybrid closed loop
Closed-Loop Trial to
Closed
algorithm that can run on a begin later in 2016.
Loop (IDCL)
pump or on a smartphone
System recently
Consortium
app.
tested in two ski
(TypeZero,
studies in
UVA, and nine - Dexcom CGM.
Wintergreen and
other academic
- Trial will use multiple
Breckenridge
institutions)
pumps; Cellnovo has

Cellnovo +
other
undisclosed
pump
companies

Beta Bionics

signed on thus far.

- Bionic Pancreas iLet

device: dual chambered
pump with built-in
algorithm; hybrid or fully
closed loop; insulin-only or
insulin+glucagon; custom
infusion set
- Dexcom CGM

Pivotal trial to start in

mid-2017
Insulin-only FDA
submission by end
of 2017.

Insulin+Glucagon
- Likely to launch as insulin- FDA submission
only product, with
potentially in 2019.
glucagon to be optionally
added later

Bigfoot
Biomedical

- Former Asante pump

body (disposable), reusable
Pivotal study in first
Bluetooth-enabled
half of 2017, FDA
controller (no screen or
submission by the
buttons) with built-in
end of 2017.
algorithm
- Dexcom CGM
- Smartphone app to serve
as complete user interface.

Launch by the end of

2018.

Animas

- Animas pump with built-in

HypoglycemiaPivotal study to begin
Hyperglycemia Minimizer in 2016, launch by
algorithm
November 2017.
- Dexcom CGM

Insulet

- OmniPod with hybrid

closed loop algorithm and
built-in Bluetooth
First clinical trials
starting later in 2016,
- Smartphone app and/or
in market in late
backup PDM handheld to
2018.
communicate with pod
- Dexcom CGM

Cellnovo

Roche

No design details disclosed,

but algorithm likely to
reside in wireless handheld - IDCL study starting
in 2016
that controls body-worn
patch pump.
- Diabeloop trials
were expected to
start at the end of
- IDCL Consortium Partner 2015, with European
(see above)
approval programs to
run until 2018
- Diabeloop consortium
partner
Working internally on a
new CGM, with future

On our agenda

CGM expected to
potential application to an
launch in Europe in
artificial pancreas device
2016

Cambridge

Commercialization
Upcoming long-term
studies will use Medtronics plans unknown. Three
upcoming studies
MiniMed 640G/Enlite 3 +
ranging from three to
Android phone running
24 months in length.
Cambridges MPC.